FDA approves first ever DNA test to help screen for risk of opioid use disorder
[ The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the AutoGenomics AvertD test for use among adults who are considering treating acute pain with short-term prescription of opioid pain medicine, such as … Read more
